BDBM218522 (r)-7-(4-chlorobenzyl)-6- ((1-cyclopropylethyl) amino)-8-(5-methyl-2-(3- (methylamino)-3- oxopropoxy)phenyl)-7h- purine-2-carboxylic acid::US9540377, 4.13

SMILES CNC(=O)CCOc1ccc(C)cc1-c1nc2nc(nc(N[C@H](C)C3CC3)c2n1Cc1ccc(Cl)cc1)C(O)=O

InChI Key InChIKey=MBDUBWZNUGPXSI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 218522   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 218522BDBM218522(US9540377, 4.13 | (r)-7-(4-chlorobenzyl)-6- ((1-cy...)
Affinity DataIC50: 487nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent